[CYCC] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
13-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 15.09%
YoY- 36.97%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 0 0 0 0 0 0 277 -
PBT -2,354 -1,531 -2,071 -2,076 -2,455 -1,861 -3,249 -19.37%
Tax -502 -182 -200 -219 -268 -306 -409 14.67%
NP -1,852 -1,349 -1,871 -1,857 -2,187 -1,555 -2,839 -24.84%
Tax Rate - - - - - - - -
Total Cost 1,852 1,349 1,871 1,857 2,187 1,555 3,116 -29.37%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -1,024.91 -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -3.09 -2.25 -3.14 -3.78 -9.86 -7.28 -13.34 -62.38%
EPS Diluted -3.09 -2.25 -3.12 -3.78 -9.86 -7.28 -13.34 -62.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.